Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Income Tax Expense Over TimeStrong
Percentile Rank100
5Y CAGR+360.0%
Studio
Year-over-Year Change

Income taxes paid or accrued

5Y CAGR
+360.0%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
2059x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$2.06M-
2024$0.00-
2023$0.00+100.0%
2022$-4000.00-107.3%
2021$55000.00+5400.0%
2020$1000.000.0%
2019$1000.000.0%
2018$1000.00-